Dextromethorphan Abuse - A Rising Menace In India: Case Review and Its Toxicokinetic
DOI:
https://doi.org/10.48165/Keywords:
Dextromethorphan, anti tussive, Adolescents, Recreational useAbstract
Dextromethorphan is a dissociative antitussive agent which is being sold freely as an over the counter drug in combination or solo in the form of tablets or syrups. The desire to be one of a kind amongst their peers is causing adolescents to experiment with different drugs. The problem is complicated with the free information available on internet regarding the new and the latest use of this drug which this savvy generation has easy access to. The recreational use of DXM is rising at a very fast pace in India and esp. Punjab. The menace needs to be checked on priority if we want to save our youth from the demon of drugs.
Downloads
References
1. Crouch BI, Caravati EM, Booth J. Trends in child and teen nonprescription drug abuse reported to a regional poison control center. Am J Health System Pharm 2004; 61: 1252- 7
2. Noonan WC, Miller WR, Feeney DM. Dextromethorphan abuse among youth. Arch Fam Med 2000; 9: 791-2.
3. Muray S, Brewton T. Abuse of over the counter dextromethorphan by teenagers. South Med J 1993; 86:1151-3.
4. Banerji S, Anderson IB. Abuse of coricidin HBP cough and cold tablets: episodes recorded by a poison center. Am J Health Syst Pharm 2001; 58: 1811-4.
5. Nevin J. Drug abuse update: dextrmethorphan. Emerg Med Serv 2004; 33:34.
6. Bornstein, S; Czermak, M; Postel, J. “Apropos of a case of voluntary medicinal intoxica tion with dextromethorphan hydrobromide”. Annals Medico-Psychologiques 1968; 1 (3): 447–451.
7. Dodds A, Revai E. «Toxic psychosis due to dextromethorphan». Med J Aust 1967; 2: 231.
8. Wolfe TR, Caravati EM. Masssive dextromethorphan ingestion and abuse. Am J Emerg Med 1995; 13: 174-6.
9. Erowid DXM Vault DXM FAQ – Side effects. Internet submission. www.erovid.org/chemi cal/dxm/dxm.shtmll.
10. Verma A, Moghaddam B. «NMDA receptor antagonists impair prefrontal cortex function as assessed via spatial delayed alternation performance in rats: modulation by dopamine». J Neurosci 1996; 1: 373–9.
11. Muir, KW; Lees KR. “Clinical experience with excitatory amino acid antagonist drugs”. Stroke 1995; 26 (3): 503–513.
12. Kristensen, JD; Svensson B, and Gordh T Jr. “The NMDA-receptor antagonist CPP abol ishes neurogenic ‘wind-up pain’ after intrathecal administration in humans”. Pain 1992; 51 (2): 249–253
13. Price LH, Lebel J. Dextrmethorphan induced psychosis. Am J Psychiatry 2000; 157:304.
14. Erowid DXM Vault- Side effects. Internet submission. www.erovid.org/chemical/dxm/ dxm.shtmll.
15. Craig DF, Psychosis with vicks formula 44-D abuse. Can Med Assoc J 1992; 146: 1199- 2000.
16. Kirages T, Sule H, Mycyk M. Severe manifestations of corcidin intoxication. Am J Emerg Med 2003; 21(6): 473-5
17. Kintz P, Mangin P. Toxicological findings in a death involving dextrmethorphan and terfnadine. Am J Forensic Med Pathol 1992; 13(4): 351-23.
18. Parks KA, Kennedy CL. Club drugs: reasons for and consequences of use. J Psychoac tive drugs 2004; 36: 295-302.
Nelson L Opiods. In: Golfrank L, Flomenbaum N , Lewin L, Weisman R, Howland M, Hoffman R (eds). Golfrank’s Toxicologic Emergencies. New York: Appleton and Lang; 1998: 975-1000.
20. Schneider SM, Michelson EA, et al Dextromethorphan poisoning reversed by naloxone. Am J Emerg Med 1991; 9: 237-238.
21. Erowid DXM Vault –Legal status. Internet submission. www.erovid.org/chemical/dxm/ dxm.shtmll.
